|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||||||||||||
|
|||||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sA883482E-5F26-11EF-A37D-467185CE164B&I=39IZM&T=&OP=Display&O=html&O1=15720074&O2=3710000000303842&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DTolerability%2520and%2520immunogenicity%2520of%2520an%2520intranasally-administered%2520adenovirus-vectored%2520COVID-19%2520vaccine%253A%2520An%2520open-label%2520partially-randomised%2520ascending%2520dose%2520phase%2520I%2520trial%26rft.au%3DAboagye%252C%2520Jeremy%26rft.au%3DJenkin%252C%2520Daniel%26rft.au%3DMadhavan%252C%2520Meera%26rft.au%3DRitchie%252C%2520Adam%2520J.%26rft.date%3D2022-11-01%26rft.eissn%3D2352-3964%26rft.externalDBID%3DPMC9550199%26rft.genre%3Darticle%26rft.jtitle%3DEBioMedicine%26rft.pub%3DThe%2520Authors.%2520Published%2520by%2520Elsevier%2520B.V%26rft_id%3Dinfo%253Adoi%252F10.1016%252Fj.ebiom.2022.104298%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS-getFullTxt-object,2-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_20221021_LCL-getFullTxt-object,3-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_OILJ_LCL-getFullTxt-object,4-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_PNG_LCL-getFullTxt-object,5-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_UL_LCL-getFullTxt-object,6-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_UM_LCL-getFullTxt-object,7-ELSEVIER_SCIENCEDIRECT_AUTOLOAD_JOURNALS_UP_LCL-getFullTxt-object,8-UNPAYWALL-getFullTxt-object,9-PUBMED_CENTRAL_JOURNALS-getFullTxt-object,10-DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS-getFullTxt-object,11-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,12-DOI-getDOI-object,13-COBIB_SI_LCL-getHolding-object,14-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,15-REFWORKS_EXPORT_TOOL-getReference-object,16-SHERPA_RoMEO_LCL-getWebService-object,17-GOOGLE_SCHOLAR_FREE-getWebSearch-object,18-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.113733&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15720074-sA883482E-5F26-11EF-A37D-467185CE164B" timestamp="2024-08-20T21:01:51Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:3710000000303842</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial</jnl:atitle>
<jnl:jtitle>Ebiomedicine</jnl:jtitle>
<jnl:date>2022-11-00</jnl:date>
<jnl:spage>104298</jnl:spage>
<jnl:issn>2352-3964</jnl:issn>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2352-3964</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:7ae8e10495900a8e53026e0dad399c11c4011184</ctx:identifier>
<ctx:identifier>urn:UUID:sA883482E-5F26-11EF-A37D-467185CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)